Pulmonary alveolar proteinosis and cement dust: a case report - a preliminary report.
McCunney RJ; Godefroi R
Proceedings of the VIIth International Pneumoconioses Conference, August 23-26, 1988, Pittsburgh, Pennsylvania, USA. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 90-108, 1990 Nov; (Part II):852-861
A case of pulmonary alveolar proteinosis (PAP) due to occupational exposure to cement dust was examined. A 29 year old white male who had been recently diagnosed with PAP was referred for an occupational medical consultation. He had been employed as a cement truck driver in a railroad freight yard for 2 years. He had smoked 1.5 packs of cigarettes a day for 15 years. A review of his clinical history confirmed the diagnosis of PAP. Lung biopsy specimens obtained by bronchoscopy were analyzed for silica (14808607) by electron dispersive spectroscopy. Silica particles were found in the macrophages and alveolar fluid. A review of the patient's occupational history revealed that he had been heavily exposed to Portland-cement (65997151). He stated that his hair, nose, and skin were covered with dust by the end of the working day. He did not use any respiratory protection. Air monitoring of cement dust had not been performed at the patient's workplace. A review of published data on the composition of Portland and other types of cement revealed that the dusts to which the patient was exposed contained at least 20% silica. The authors conclude that the patient developed PAP probably as a response to occupational exposure to Portland-cement dust. It cannot be determined with certainty if he is at risk of a recurrence of PAP if he receives further exposure to cement dust. Since PAP is a potential life threatening illness such exposure should be avoided.
Case studies; Respiratory system disorders; Dust exposure; Occupational exposure; Cements; Risk analysis; Silica dusts; Chemical composition; Clinical diagnosis
DHHS (NIOSH) Publication No. 90-108
Proceedings of the VIIth International Pneumoconioses Conference, August 23-26, 1988, Pittsburgh, Pennsylvania, USA
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.